Measuring muscle strength and size in people with inflammatory bowel disease.
Official title: Evaluation of Sarcopenia in Patients With Inflammatory Bowel Disease
Run by Sakarya University · NCT07441447 · Data updated 2026-11-12
This project will test whether ultrasound measurements of selected muscles, together with handgrip strength, can serve as a practical alternative to CT-based muscle measurements for adults with inflammatory bowel disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Sakarya University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Sakarya, Adapazarı) |
| Status | Recruiting |
| Started | November 10, 2025 |
| Main results expected | November 10, 2026 |
| Study ends | December 2026 |
| Registry record updated | March 2, 2026 |
| Trial ID | NCT07441447 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with a confirmed diagnosis of IBD who can provide informed consent, undergo handgrip testing and muscle ultrasound, and have an abdominal CT performed within the previous six months are ideal candidates.
✕Probably not a fit
Patients with known neuromuscular disorders, major orthopedic limitations affecting strength testing, abdominal wall defects, pregnancy, or incomplete clinical or imaging data are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-center observational project enrolls adults with confirmed IBD to measure muscle strength and muscle mass using handgrip dynamometry and targeted muscle ultrasonography. Selected muscles (rectus femoris, vastus intermedius, gastrocnemius medialis, biceps brachii, rectus abdominis, and internal oblique) will be measured for thickness and cross-sectional area by ultrasound. For participants with an abdominal CT within the previous six months, L3 skeletal muscle cross-sectional area will be measured from archived images to compare with ultrasound results. The primary outcome is the correlation and agreement between ultrasound-based measures and CT-derived L3 muscle area.
Why it matters
Potential benefit: If successful, ultrasound could offer a fast, radiation-free, and more accessible way to monitor muscle mass in patients with IBD.
How similar studies have gone: Ultrasound has shown promising agreement with CT for muscle measurement in other patient groups, but validation specifically in IBD populations remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Established diagnosis of inflammatory bowel disease (ICD-10: K50.\* Crohn's disease, K51.\* ulcerative colitis) * Ability to provide written informed consent * Ability to undergo ultrasonographic muscle assessment and handgrip strength testing * Availability of an abdominal computed tomography (CT) scan performed within the previous 6 months Exclusion Criteria: * Known neuromuscular disorders or primary muscle diseases * Major orthopedic conditions affecting muscle strength assessment * Pregnancy * Abdominal wall defects or conditions interfering with ultrasound assessment * Incomplete clinical or imaging data * Any condition preventing reliable ultrasound or handgrip measurement
Where it's running
-
Sakarya University Faculty of Medicine, Training and Research Hospital
Sakarya, Adapazarı, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Yunus Günegül
- Email: yunusgunegul@sakarya.edu.tr
- Phone: +905386046017
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reduce ultra-processed foods to help kids with Crohn's stay in remission longer
This study tests whether and how reducing ultra-processed foods with dietitian guidance helps children and teens with Crohn's disease stay in remission longer.
-
Endoscopic stricturotomy vs balloon dilation for small bowel Crohn’s stricture
This trial tests whether endoscopic stricturotomy can be safely and effectively used to treat small bowel fibrotic strictures in Crohn’s disease, compared with endoscopic balloon dilation.
-
Prediction of postoperative recurrence in Crohn's disease after surgery
A multicenter study will test a multimodal model to predict which Crohn's patients are likely to have disease recur after intestinal resection.
-
Perianal fistula imaging comparison using TPUS, MRI, EUS, and EUA
This study tests how well four imaging methods—transperineal ultrasound, MRI, endoscopic ultrasound, and examination under anesthesia—detect and describe perianal fistulas in adults with Crohn's disease or unknown cause.
-
Familial IBD Early Risk
This study tests whether clinical, environmental, and immune factors in first-degree relatives of people with Crohn’s disease or ulcerative colitis can predict who will develop IBD.
-
Impact of sucralose on gut health in Crohn's disease
This study tests whether the non-nutritive sweetener sucralose changes gut bacteria in adults with Crohn's disease compared to healthy controls.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.